Literature DB >> 2355017

Inter-tissue and inter-species characteristics of the mitochondrial carnitine palmitoyltransferase enzyme system.

K F Woeltje1, V Esser, B C Weis, W F Cox, J G Schroeder, S T Liao, D W Foster, J D McGarry.   

Abstract

Properties of the carnitine palmitoyltransferase (EC 2.3.1.21) (CPT) enzyme system were compared in isolated mitochondria from a range of tissues in rodents, monkey, and man. Common features were as follows: (a) while membrane-bound, CPT I, but not CPT II, was inhibited reversibly by malonyl-coenzyme A (CoA) and irreversibly by CoA esters of certain oxirane carboxylic acids; (b) the detergent, Tween-20, readily solubilized CPT II in active form while leaving CPT I membrane associated and catalytically functional; (c) octyl glucoside and Triton X-100 released active CPT II but caused essentially complete loss of CPT I activity. Use of [3H]tetradecylglycidyl-CoA, a covalent ligand for CPT I, yielded estimates of the enzyme's monomeric molecular size: approximately 86 kDa in non-hepatic tissues and approximately 90-94 kDa in liver, depending upon species. A polyclonal antibody to purified rat liver CPT II recognized a single protein in each tissue; its apparent molecular mass was approximately 70 kDa in all rat tissues and approximately 68 kDa in all mouse tissues as well as monkey and human liver. On Northern blot analysis a rat liver CPT II cDNA probe detected a single approximately 2.5-kilobase mRNA in all rat and mouse tissues examined. The following points are emphasized. First, CPT I and II are different proteins. Second, within a species CPT II, but not CPT I, is probably conserved across tissue lines. Third, slight variations in size of both enzymes were found in different species, although, at least in the case of CPT II, significant amino acid identity exists among the various isoforms. Fourth, CPT I, unlike CPT II, requires membrane integrity for catalytic function. Finally, the strategic use of detergents provides a simple means of discriminating between the two enzyme activities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355017

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Regulation of the expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene. Its role in the control of ketogenesis.

Authors:  N Casals; N Roca; M Guerrero; G Gil-Gómez; J Ayté; C J Ciudad; F G Hegardt
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Correction of diabetic alterations by glucokinase.

Authors:  T Ferre; A Pujol; E Riu; F Bosch; A Valera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Alteration of regulatory enzyme activities in fast-twitch and slow-twitch muscles and muscle fibres in low-intensity endurance-trained rats.

Authors:  H O Tikkanen; H K Näveri; M H Härkönen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

4.  Development and characterization of a polyclonal antibody against rat liver mitochondrial overt carnitine palmitoyltransferase (CPT I). Distinction of CPT I from CPT II and of isoforms of CPT I in different tissues.

Authors:  M P Kolodziej; P J Crilly; C G Corstorphine; V A Zammit
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

5.  Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A.

Authors:  S Zierz; S Neumann-Schmidt; F Jerusalem
Journal:  Clin Investig       Date:  1993-10

6.  Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-I by a mechanism involving phospholipids.

Authors:  R L Mynatt; J J Greenhaw; G A Cook
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

7.  Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation.

Authors:  M M Awan; E D Saggerson
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

8.  Expression of precursor and mature carnitine palmitoyltransferase II in Escherichia coli and in vitro: differential behaviour of rat and human isoforms.

Authors:  N F Brown; A Sen; D A Soltis; B Jones; D W Foster; J D McGarry
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

9.  Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency.

Authors:  S Zierz
Journal:  Clin Investig       Date:  1994-12

10.  Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene.

Authors:  C H Britton; R A Schultz; B Zhang; V Esser; D W Foster; J D McGarry
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.